- Report
- February 2024
- 150 Pages
Global
From €4658EUR$4,750USD£3,881GBP
- Report
- February 2024
- 120 Pages
Global
From €4658EUR$4,750USD£3,881GBP
- Report
- February 2024
- 100 Pages
Global
From €4658EUR$4,750USD£3,881GBP
- Report
- March 2024
- 30 Pages
Global
From €1888EUR$1,925USD£1,573GBP
€2697EUR$2,750USD£2,247GBP
- Drug Pipelines
- November 2024
- 80 Pages
Global
From €1961EUR$2,000USD£1,634GBP
- Clinical Trials
- November 2024
- 80 Pages
Global
From €1961EUR$2,000USD£1,634GBP
- Report
- November 2024
- 145 Pages
Global
From €5457EUR$5,565USD£4,547GBP
€7796EUR$7,950USD£6,496GBP
- Clinical Trials
- August 2024
- 240 Pages
Global
From €2059EUR$2,100USD£1,716GBP
€2942EUR$3,000USD£2,451GBP
- Report
- August 2024
- 150 Pages
Global
From €2574EUR$2,625USD£2,145GBP
€3677EUR$3,750USD£3,064GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1373EUR$1,400USD£1,144GBP
€1961EUR$2,000USD£1,634GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2059EUR$2,100USD£1,716GBP
€2942EUR$3,000USD£2,451GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €858EUR$875USD£715GBP
€1226EUR$1,250USD£1,021GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €858EUR$875USD£715GBP
€1226EUR$1,250USD£1,021GBP
- Clinical Trials
- April 2024
- 115 Pages
Global
From €1373EUR$1,400USD£1,144GBP
€1961EUR$2,000USD£1,634GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €858EUR$875USD£715GBP
€1226EUR$1,250USD£1,021GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1373EUR$1,400USD£1,144GBP
€1961EUR$2,000USD£1,634GBP
- Report
- February 2024
- 182 Pages
Global
From €5457EUR$5,565USD£4,547GBP
€7796EUR$7,950USD£6,496GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1030EUR$1,050USD£858GBP
€1471EUR$1,500USD£1,226GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €1226EUR$1,250USD£1,021GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €1226EUR$1,250USD£1,021GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more